The push to revive extinct animals is accelerating, but scientists disagree about whether gene-edited species count as true ...

Gov. Dan McKee has appointed William Tsonos to chair the Rhode Island Life Science Hub, replacing interim chair Stefan Pryor.

This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.

Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in ...

Shares of Structure Therapeutics rallied 10% in premarket trade on Monday after the company said higher doses of its ...

Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...

Structure Therapeutics said its GLP-1 pill helped patients lose more than 16% of their body weight in a midstage trial, ...

Its tech talent and endogamous cohorts make it unique.

Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.